Raul R. Rodriguez is CEO & President at RIGEL PHARMACEUTICALS INC (RIGL). They have made 5 open-market trades across 1 company since 2018, most recently 2026-09-01.
CIK 0001190279
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $990K since 2018, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RIGL | 273,362 | $12.7M |
Shares reported on the most recent Form 4, priced at the 2026-09-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RIGL | SELL | 2025-02-04 | 2025-02-06 | $21.23 | $304K | -14.9% | -19.4% | -23.8% |
| RIGL | SELL | 2024-02-02 | 2024-02-06 | $1.14 | $60K | -3.3% | +26.4% | +0.8% |
| RIGL | SELL | 2023-02-06 | 2023-02-07 | $1.75 | $36K | -7.9% | -1.5% | -30.2% |
| RIGL | BUY | 2022-06-09 | 2022-06-13 | $0.69 | $690K | +43.7% | +87.3% | +101.4% |
| RIGL | BUY | 2018-08-17 | 2018-08-21 | $2.63 | $300K | +21.8% | +18.6% | -4.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.